Article
NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome".
Human mutation - 1 Feb 2010
Guillot Loïc, Carré Aurore, Szinnai Gabor, Castanet Mireille, Tron Elodie, Jaubert Francis, Broutin Isabelle, Counil François, Feldmann Delphine, Clement Annick, Polak Michel, Epaud Ralph
Abstract excerpt
NKX2-1 (NK2 homeobox 1) is a critical regulator of transcription for the surfactant protein (SP)-B and -C genes (SFTPB and SFTPC, respectively). We identified and functionally characterized two new de novo NKX2-1 mutations c.493C>T (p.R165W) and c.786_787del2 (p.L263fs) in infants with closely similar severe interstitial lung disease (ILD), hypotonia, and congenital hypothyroidism. Functional analyses using A549...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
